Found: 65
Select item for more details and to access through your institution.
Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 424, doi. 10.3390/jpm11050424
- By:
- Publication type:
- Article
Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34025-x
- By:
- Publication type:
- Article
Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 385, doi. 10.3390/ph13110385
- By:
- Publication type:
- Article
Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don't) know.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. N.PAG, doi. 10.1186/s13046-020-01721-9
- By:
- Publication type:
- Article
Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non–small Cell Lung Cancer.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 5, p. 1, doi. 10.1007/s11912-020-00908-9
- By:
- Publication type:
- Article
Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 9, p. 1, doi. 10.1007/s11912-016-0544-7
- By:
- Publication type:
- Article
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9429, doi. 10.3390/ijms24119429
- By:
- Publication type:
- Article
Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2438, doi. 10.3390/jcm9082438
- By:
- Publication type:
- Article
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987639
- By:
- Publication type:
- Article
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987639
- By:
- Publication type:
- Article
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231198446
- By:
- Publication type:
- Article
Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0954-5
- By:
- Publication type:
- Article
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
- By:
- Publication type:
- Article
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non-Small-Cell Lung Cancer With the Absenc of Epidermal Growth Factor Receptor Mutations
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 2, p. 138, doi. 10.1016/j.cllc.2011.03.008
- By:
- Publication type:
- Article
The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs.
- Published in:
- Scientific Reports, 2016, p. 39217, doi. 10.1038/srep39217
- By:
- Publication type:
- Article
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
- Published in:
- Scientific Reports, 2015, p. 16331, doi. 10.1038/srep16331
- By:
- Publication type:
- Article
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429
- By:
- Publication type:
- Article
Atezolizumab in a C o H ort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal Subtyp E s (CHANCE trial).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920915983
- By:
- Publication type:
- Article
Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0059981
- By:
- Publication type:
- Article
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study.
- Published in:
- BMC Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10427-4
- By:
- Publication type:
- Article
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2429, doi. 10.1007/s00262-021-02916-5
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1663, doi. 10.3390/cancers13071663
- By:
- Publication type:
- Article
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1300, doi. 10.3390/cancers13061300
- By:
- Publication type:
- Article
Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1165, doi. 10.3390/cancers13051165
- By:
- Publication type:
- Article
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 583, doi. 10.3390/cancers13030583
- By:
- Publication type:
- Article
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 555, doi. 10.3390/cancers13030555
- By:
- Publication type:
- Article
The Potential of T Cell Factor 1 in Sustaining CD8 + T Lymphocyte-Directed Anti-Tumor Immunity.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 515, doi. 10.3390/cancers13030515
- By:
- Publication type:
- Article
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2948, doi. 10.3390/cancers12102948
- By:
- Publication type:
- Article
Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 546, doi. 10.3390/cancers12030546
- By:
- Publication type:
- Article
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 67, doi. 10.3390/cancers12010067
- By:
- Publication type:
- Article
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- Letter
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 9, p. 1, doi. 10.1002/cam4.7159
- By:
- Publication type:
- Article
Review: Targeted therapies in small cell lung cancer: a review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 1, p. 25, doi. 10.1177/1758834009356014
- By:
- Publication type:
- Article
Maintenance therapy in NSCLC: why? To whom? Which agent?
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2011, v. 30, n. 1, p. 50, doi. 10.1186/1756-9966-30-50
- By:
- Publication type:
- Article
A mono-institutional prospective study on the effectiveness of a specialist psychotherapeutic intervention (POI) started at the diagnosis of cancer.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 3, p. 475, doi. 10.1007/s00520-011-1096-x
- By:
- Publication type:
- Article
Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.
- Published in:
- Biomedicine Hub, 2020, v. 5, n. 3, p. 1, doi. 10.1159/000511209
- By:
- Publication type:
- Article
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
- Published in:
- Frontiers in Psychology, 2023, p. 01, doi. 10.3389/fpsyg.2023.1062830
- By:
- Publication type:
- Article
Regulation of PD-L1 Expression by NF-κB in Cancer.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.584626
- By:
- Publication type:
- Article
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population‐based nationwide study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1661, doi. 10.1111/1759-7714.13456
- By:
- Publication type:
- Article
PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
- Published in:
- Molecular Cancer, 2024, v. 23, p. 1, doi. 10.1186/s12943-024-02014-x
- By:
- Publication type:
- Article
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- Letter